|
業務類別
|
Biotechnology |
|
業務概覽
|
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis. |
| 公司地址
| 501 Canal Boulevard, Richmond, CA, USA, 94804 |
| 電話號碼
| +1 510 970-6000 |
| 傳真號碼
| +1 510 236-8951 |
| 公司網頁
| https://www.sangamo.com |
| 員工數量
| 183 |
| Mr. Scott B. Willoughby |
General Counsel and Corporate Secretary |
-- |
30/04/2025 |
| Mr. Gregory Davis, PhD |
Head of Research and Technology |
-- |
30/04/2025 |
| Dr. Alexander Donald Macrae, M.B.,PhD |
Director, President and Chief Executive Officer |
美元 716.37K |
30/04/2025 |
| Ms. Amy Pooler, PhD |
Vice President and Head of Research |
-- |
19/04/2024 |
| Mr. Nikunj Jain |
Interim Chief Financial Officer, Principal Accounting Officer, Vice President, Finance and Corporate Controller |
-- |
03/02/2026 |
| Ms. Nathalie Dubois-Stringfellow, PhD |
Chief Development Officer |
美元 453.60K |
30/04/2025 |
|
|
| Mr. Robert F. Carey |
Independent Director |
30/04/2025 |
| Ms. Courtney Beers |
Independent Director |
30/04/2025 |
| Ms. Margaret A. Horn, J.D. |
Independent Director |
30/04/2025 |
| Dr. John H. Markels, PhD |
Independent Director |
30/04/2025 |
| Dr. Karen L. Smith, L.L.M.,M.B.A.,M.D.,PhD |
Independent Director |
30/04/2025 |
| Dr. Alexander Donald Macrae, M.B.,PhD |
Director, President and Chief Executive Officer |
30/04/2025 |
| Dr. Kenneth J. Hillan, Ch.B.,M.B. |
Independent Director |
30/04/2025 |
| Mr. James R. Meyers |
Independent Director |
30/04/2025 |
| Ms. H. Stewart Parker |
Chairwoman of the Board |
30/04/2025 |
|
|
|
|
